IAK:NYE-iShares U.S. Insurance ETF (USD)

ETF | Financial |

Last Closing

USD 129.36

Change

+0.31 (+0.24)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Financial

Symbol Name Price(Change) Market Cap
XLF Financial Select Sector SPDR®..

-0.24 (-0.53%)

USD 42.90B
VFH Vanguard Financials Index Fund..

-0.71 (-0.65%)

USD 10.13B
FNCL Fidelity® MSCI Financials Ind..

-0.48 (-0.75%)

USD 1.77B
BIZD VanEck BDC Income ETF

-0.58 (-3.50%)

USD 1.20B
FXO First Trust Financials AlphaDE..

-0.46 (-0.90%)

USD 0.92B
VPC Virtus Private Credit ETF

-0.22 (-0.98%)

USD 0.05B
BDCZ UBS AG London Branch ELKS 4

-0.15 (-0.78%)

USD 0.02B
IYF iShares U.S. Financials ETF

-0.79 (-0.76%)

N/A
IYG iShares U.S. Financial Service..

-0.58 (-0.82%)

N/A
IAI iShares U.S. Broker-Dealers & ..

-0.92 (-0.72%)

N/A

ETFs Containing IAK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Financial) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.20% 100% F 90% A-
Dividend Return 1.16% 24% F 22% F
Total Return 30.36% 100% F 89% A-
Trailing 12 Months  
Capital Gain 44.20% 82% B 86% B+
Dividend Return 1.77% 18% F 24% F
Total Return 45.97% 76% C+ 86% B+
Trailing 5 Years  
Capital Gain 86.29% 88% B+ 81% B-
Dividend Return 8.97% 29% F 29% F
Total Return 95.26% 88% B+ 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 17.03% N/A N/A 80% B-
Dividend Return 18.73% N/A N/A 80% B-
Total Return 1.70% N/A N/A 39% F
Risk Return Profile  
Volatility (Standard Deviation) 18.66% N/A N/A 55% F
Risk Adjusted Return 100.37% N/A N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike